Display options
Share it on

P T. 2014 Jul;39(7):517.

Huge growth seen in hepatitis C market.

P & T : a peer-reviewed journal for formulary management

Kunj Gohil

PMID: 25083130 PMCID: PMC4103579

Abstract

As better drugs from a variety of pharmaceutical industry players enter a market with millions of untreated patients, U.S. spending on hepatitis C treatments is expected to rise from $2.1 billion in 2012 to $6.5 billion in 2022.

Publication Types